Bovie Medical Corporation Announces Third Quarter 2016 Earnings Call
October 11 2016 - 8:00AM
Business Wire
Bovie Medical (NYSE MKT:BVX), a maker of medical devices
and supplies and the developer of J-Plasma®, a patented new
surgical product, today announced that its third-quarter 2016
earnings conference call will take place at 4:30 p.m. ET on
Wednesday, October 26.
To listen to the call by phone, interested parties within the
U.S. should call 800-862-9098. International callers should call
785-424-1051. Participants should ask for the Bovie Medical
Corporation Call. The conference call will also be available
through a live webcast at Bovie Medical Corporation’s website or at
http://www.investorcalendar.com/IC/CEPage.asp?ID=175324.
A replay of the call will be available approximately two hours
after the end of the call through November 26, 2016. The replay can
be accessed via Bovie Medical Corporation’s website or by dialing
877-481-4010 for U.S. callers or 919-882-2331 for International
callers and using the replay access code 10093.
Bovie’s financial results for the quarter ended September 30,
2016 will be issued after market, before the conference call.
About Bovie Medical Corporation
Bovie Medical Corporation is a leading maker of medical devices
and supplies as well as the developer of J-Plasma®, a patented new
plasma-based surgical product for cutting and coagulation.
J-Plasma® utilizes a helium ionization process to produce a stable,
focused beam of ionized gas that provides surgeons with greater
precision, minimal invasiveness and an absence of conductive
currents through the patient during surgery. Bovie Medical
Corporation is also a leader in the manufacture of a range of
electrosurgical products and technologies, marketed through both
private labels and the Company’s own well-respected brands (Bovie®,
Aaron®, IDS™ and ICON™) to distributors worldwide. The Company also
leverages its expertise through original equipment manufacturing
(OEM) agreements with other medical device manufacturers. For
further information about the Company’s current and new products,
please refer to the Investor Relations section of Bovie Medical
Corporation’s website www.boviemed.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161011005346/en/
Investor Relations:MBS Value PartnersLynn Morgen/ Jane
Searle212-710-9686investor.relations@boviemed.com
Bovie (AMEX:BVX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Bovie (AMEX:BVX)
Historical Stock Chart
From Sep 2023 to Sep 2024